Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.
|
journal
|
October 1996 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
|
text
|
January 2010 |
Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus
|
journal
|
September 2013 |
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
|
journal
|
November 2008 |
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
|
journal
|
May 2014 |
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
|
journal
|
April 2013 |
Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
|
journal
|
April 2014 |
The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
|
journal
|
June 2013 |
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
|
journal
|
January 2005 |
Refinement of severely incomplete structures with maximum likelihood in BUSTER–TNT
|
journal
|
November 2004 |
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
|
journal
|
July 2013 |
Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility
|
journal
|
January 2014 |
A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
|
journal
|
December 2013 |
A decade after SARS: strategies for controlling emerging coronaviruses
|
text
|
January 2013 |
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
|
journal
|
December 2011 |
Human Infection with MERS Coronavirus after Exposure to Infected Camels, Saudi Arabia, 2013
|
journal
|
June 2014 |
Rapid generation of a mouse model for Middle East respiratory syndrome
|
journal
|
March 2014 |
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|
journal
|
October 2013 |
Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness
|
text
|
January 2014 |
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine
|
journal
|
May 2007 |
DNA Priming Prior to Inactivated Influenza A(H5N1) Vaccination Expands the Antibody Epitope Repertoire and Increases Affinity Maturation in a Boost-Interval–Dependent Manner in Adults
|
journal
|
April 2013 |
Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding Domain
|
journal
|
May 2009 |
Rapid generation of a mouse model for Middle East respiratory syndrome
|
text
|
January 2014 |
Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness
|
journal
|
September 2014 |
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
Inhibition of Middle East Respiratory Syndrome Coronavirus Infection by Anti-CD26 Monoclonal Antibody
|
journal
|
September 2013 |
Sustained Peptide-Specific Gamma Interferon T-Cell Response in Rhesus Macaques Immunized with Human Immunodeficiency Virus gag DNA Vaccines
|
journal
|
October 2002 |
Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant
|
journal
|
October 2007 |
A decade after SARS: strategies for controlling emerging coronaviruses
|
journal
|
November 2013 |
The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters
|
journal
|
July 2013 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
DNA-Mediated Immunization in Mice Induces a Potent MHC Class I-Restricted Cytotoxic T Lymphocyte Response to the Hepatitis B Envelope Protein
|
journal
|
November 1995 |
Three-dimensional structure of an Fv from a human IgM immunoglobulin
|
journal
|
November 1992 |
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
|
journal
|
April 2004 |
Middle East Respiratory Syndrome Coronavirus Quasispecies That Include Homologues of Human Isolates Revealed through Whole-Genome Analysis and Virus Cultured from Dromedary Camels in Saudi Arabia
|
journal
|
April 2014 |
Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
|
text
|
January 2014 |
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
|
journal
|
July 2007 |
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
A Generic Approach to Pathological Lung Segmentation
|
journal
|
December 2014 |
Two is better than one
|
journal
|
December 2011 |
Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein
|
journal
|
April 2014 |
Exploring the gas access routes in a [NiFeSe] hydrogenase using crystals pressurized with krypton and oxygen
|
journal
|
August 2020 |
Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
|
journal
|
April 2014 |
Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells
|
journal
|
July 1988 |
Assessing the pandemic potential of MERS-CoV
|
journal
|
August 2013 |
PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome
|
journal
|
December 2019 |
Cavin1 intrinsically disordered domains are essential for fuzzy electrostatic interactions and caveola formation
|
journal
|
February 2021 |
Rapid lateral flow immunoassay for the fluorescence detection of SARS-CoV-2 RNA
|
journal
|
December 2020 |
Coronavirus IBV: Structural Characterization of the Spike Protein
|
journal
|
December 1983 |
Features and development of Coot
|
journal
|
March 2010 |
A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
|
journal
|
April 2014 |
Is MERS another SARS?
|
journal
|
September 2013 |
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
|
journal
|
September 2013 |
Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
|
journal
|
August 2013 |
Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity
|
journal
|
June 2004 |
Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect
|
journal
|
April 2013 |
Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus
|
text
|
January 2013 |
A Human T-Cell Leukemia Virus Type 1 Regulatory Element Enhances the Immunogenicity of Human Immunodeficiency Virus Type 1 DNA Vaccines in Mice and Nonhuman Primates
|
journal
|
June 2005 |
Modulation of the Immune Response to the Severe Acute Respiratory Syndrome Spike Glycoprotein by Gene-Based and Inactivated Virus Immunization
|
journal
|
October 2005 |
Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody
|
journal
|
April 2006 |
Inhibitory effects of aprotinin on influenza A and B viruses in vitro and in vivo
|
journal
|
May 2021 |
A Simple Method of Estimating Fifty per cent Endpoints12
|
journal
|
May 1938 |
Phaser crystallographic software
|
journal
|
July 2007 |
DNA vaccination: antigen presentation and the induction of immunity
|
journal
|
December 2000 |